Coronavirus: Using European supercomputing, EU-funded research project demonstrates promising results for potential treatment

The EU-funded consortium Exscalate4CoV just announced that an already registered generic drug used to treat osteoporosis, Raloxifene, could be an effective treatment for COVID-19 positive patients with mild or asymptomatic infection. The consortium is using an EU-backed supercomputing platform, one of the world's most powerful, to check the potential impact of known molecules against the genomic structure of coronavirus.